Nasdaq Resumes Trading in Statera Biopharma, Inc.
The Nasdaq Stock Market announced that trading in Statera Biopharma resumed on August 26, 2022, at 7:10 a.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Nasdaq Stock Market announced that trading in Statera Biopharma resumed on August 26, 2022, at 7:10 a.m. Eastern Time. This follows a halt in trading that occurred a day earlier, on August 25, 2022, at 11:01:52 a.m. Eastern Time. The resumption of trading indicates regulatory clearance, but further details regarding the reasons for the halt or any specific developments regarding Statera Biopharma were not provided in the announcement.
Details
News Market Reaction – NDAQ
The recorded move for NDAQ in the trading session of this news was -2.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading resumed in Statera Biopharma, Inc. (Nasdaq: STAB) today, August 26, 2022 at 7:10 a.m. Eastern Time. Trading in the company’s stock was halted on August 25, 2022 at 11:01:52 a.m. Eastern Time.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Nasdaq Media Contact:
Sophia Weiss
Sophia.Weiss@nasdaq.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.